Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | PRTA | TRDA | ||
| Company | Urovant Sciences Ltd | Prothena Corp | Entrada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 9.75 | 13.27 | ||
| High | 16.24 | 10.08 | 13.53 | ||
| Low | 16.21 | 9.51 | 12.90 | ||
| Latest | 16.24 | 9.82 | 13.03 | ||
| Change | +0.01 | -0.21 | -0.45 | ||
| % Change | +0.06% | -2.09% | -3.34% | ||
| Volume | 1,739,000 | 578,324 | 48,921 | ||
| 20-Day Average Volume | 143,510 | 576,409 | 206,938 | ||
| Previous Close | 16.23 | 10.03 | 13.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 9.29 | 12.41 | ||
| 20-Day Raw Stochastic | 87.10% | 79.39% | 75.51% | ||
| 20-Day Relative Strength | 65.56 | 57.53 | 56.89 | ||
| Weighted Alpha | +6.45 | +15.47 | +79.21 | ||
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +3.78% since 03/26/26 | +5.61% since 03/26/26 | ||
| Low | 16.20 on 03/24/21 | 9.11 on 03/30/26 | 11.50 on 03/30/26 | ||
| High | 16.25 on 03/25/21 | 10.11 on 04/01/26 | 13.66 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +5.11% since 03/02/26 | +11.30% since 03/02/26 | ||
| Low | 16.10 on 03/02/21 | 8.38 on 03/19/26 | 10.97 on 03/24/26 | ||
| High | 16.26 on 03/19/21 | 10.27 on 03/10/26 | 13.66 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +7.39% since 01/02/26 | +29.35% since 01/02/26 | ||
| Low | 16.03 on 12/30/20 | 8.19 on 02/20/26 | 9.33 on 01/12/26 | ||
| High | 16.26 on 03/19/21 | 10.53 on 01/23/26 | 13.66 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -1.10% since 10/02/25 | +119.59% since 10/02/25 | ||
| Low | 7.15 on 11/02/20 | 8.19 on 02/20/26 | 5.55 on 10/14/25 | ||
| High | 16.26 on 03/19/21 | 11.69 on 10/28/25 | 13.66 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 539,945 | 516,068 | ||
| Shares Outstanding, K | 32,743 | 53,833 | 38,284 | ||
| Annual Sales | 0 | 9,680,000 | 25,420,000 | ||
| Annual Net Income | -146,750,000 | -244,090,000 | -143,750,000 | ||
| Last Quarter Sales | 0 | 20,000 | 1,300,000 | ||
| Last Quarter Net Income | -46,800,000 | -21,590,000 | -39,160,000 | ||
| 60-Month Beta | 2.35 | -0.33 | -0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.44 on 02/19/26 | -0.94 on 02/26/26 | ||
| Latest Earnings Date | 06/17/21 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||